Provenge, the first immunotherapy drug to receive FDA approval for use in patients, had its origins decades ago in the lab of Edgar Engleman. Photo by Timothy Archibald /2019
sp19 provenge twitter
Popular posts
Why detecting the earliest biological signs of Parkinson’s disease is so crucial
A new test can detect the biological signature of Parkinson’s disease before symptoms arise. A Stanford Medicine neurologist explains why early diagnosis opens the door to better therapies.
Imagining virtual reality as a simple tool to treat depression
Some of the 17 million Americans afflicted with major depressive disorder each year may soon receive a surprising new prescription from their clinician: Have fun on a virtual reality device.